Data for: Dalbavancin is a promising anti-COVID-19 candidate
收藏官方服务：
资源简介：
The sourse data of the paper: Dalbavancin is a promising anti-COVID-19 candidate
应用场景：
创建时间：
2021-05-26
相关数据集
Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis
This study investigated the efficacy and safety of interleukin-6 (IL-6) receptor antagonists with standard care treatment in patients with coronavirus disease 2019 (COVID-19). The randomized controlle
DataCite Commons2025-11-18 更新60
Data_Sheet_1_Targeting Emerging RNA Viruses by Engineered Human Superantibody to Hepatitis C Virus RNA-Dependent RNA Polymerase.docx
RNA-dependent RNA polymerase (RdRp) is a unique and highly conserved enzyme across all members of the RNA virus superfamilies. Besides, humans do not have a homolog of this protein. Therefore, the RdR
NIAID Data Ecosystem30
ENEF2020_Vague Coronavirus_V3 - Indications traitement- panel-1.pdf
:unav
DataCite Commons2024-11-07 更新30
Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis
This study investigated the efficacy and safety of interleukin-6 (IL-6) receptor antagonists with standard care treatment in patients with coronavirus disease 2019 (COVID-19). The randomized controlle
DataCite Commons2025-11-18 更新60
Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial
A randomised control trial was done to assess clinical and immunological benefits of passive immunization using convalescent plasma therapy (CPT), compared with standard of care, in severe COVID-19 pa
NIAID Data Ecosystem30
